HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jiro Okami Selected Research
Jiro Okami Research Topics
Disease
33
Neoplasms (Cancer)
12/2022 - 08/2003
18
Lung Neoplasms (Lung Cancer)
10/2022 - 05/2008
18
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 01/2007
16
Neoplasm Metastasis (Metastasis)
03/2022 - 02/2003
9
Pancreatic Neoplasms (Pancreatic Cancer)
01/2008 - 01/2003
5
Adenocarcinoma of Lung
05/2022 - 12/2011
4
Lymphatic Metastasis
03/2021 - 10/2011
4
Adenocarcinoma
01/2020 - 09/2003
4
Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 02/2008
3
Malignant Mesothelioma
01/2015 - 12/2008
2
Hyperthyroidism
09/2020 - 12/2009
2
Brain Neoplasms (Brain Tumor)
01/2016 - 01/2015
2
Disease Progression
01/2016 - 05/2008
1
Meningeal Carcinomatosis
10/2022
1
Meningitis
10/2022
1
Osteosarcoma (Osteogenic Sarcoma)
03/2022
1
Sarcoma (Soft Tissue Sarcoma)
03/2022
1
Chronic Kidney Failure (Chronic Renal Failure)
01/2022
1
Chronic Renal Insufficiency
01/2022
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2021
1
Hypothyroidism
09/2020
1
Ovarian Neoplasms (Ovarian Cancer)
07/2020
1
Idiopathic Pulmonary Fibrosis
01/2016
1
Rectal Neoplasms (Rectal Cancer)
11/2015
1
Pneumothorax
01/2015
1
Fistula
01/2015
1
Hyperthermia
11/2013
Drug/Important Bio-Agent (IBA)
7
Gemcitabine
FDA Link
02/2012 - 02/2003
5
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 05/2008
5
Pharmaceutical Preparations
IBA
09/2017 - 03/2003
4
Carboplatin (JM8)
FDA Link
Generic
11/2021 - 06/2010
4
Carcinoembryonic Antigen
IBA
12/2018 - 10/2011
4
Messenger RNA (mRNA)
IBA
07/2017 - 08/2006
3
Bevacizumab (Avastin)
FDA Link
11/2021 - 11/2015
3
Biomarkers (Surrogate Marker)
IBA
01/2021 - 07/2007
3
Gefitinib (Iressa)
FDA Link
01/2015 - 01/2007
3
Glucose (Dextrose)
FDA Link
Generic
03/2012 - 08/2004
3
Fluorouracil (Carac)
FDA Link
Generic
01/2008 - 08/2006
2
Tyrosine Kinase Inhibitors
IBA
05/2022 - 12/2011
2
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 12/2011
2
Paclitaxel (Taxol)
FDA Link
Generic
11/2021 - 06/2010
2
Amino Acids
FDA Link
11/2020 - 01/2018
2
Therapeutic Uses
IBA
01/2018 - 08/2006
2
Proteins (Proteins, Gene)
FDA Link
07/2017 - 08/2004
2
Thymidylate Synthase
IBA
07/2017 - 07/2007
2
Cisplatin (Platino)
FDA Link
Generic
11/2013 - 06/2010
2
Collagen
IBA
02/2012 - 12/2008
2
Vinorelbine (Navelbine)
FDA Link
Generic
06/2010 - 08/2006
2
Antigens
IBA
01/2004 - 02/2003
2
Retinoid X Receptor alpha
IBA
09/2003 - 08/2003
2
Troglitazone (Rezulin)
FDA Link
09/2003 - 08/2003
2
PPAR gamma
IBA
09/2003 - 08/2003
2
Thiazolidinediones
IBA
09/2003 - 08/2003
2
Cytoplasmic and Nuclear Receptors (Nuclear Receptors)
IBA
09/2003 - 08/2003
2
Ligands
IBA
09/2003 - 08/2003
1
dacomitinib
IBA
10/2022
1
Afatinib
IBA
10/2022
1
Creatinine
IBA
01/2022
1
RNA (Ribonucleic Acid)
IBA
01/2022
1
atezolizumab
IBA
11/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
Nivolumab
IBA
01/2021
1
xylometazoline (stas)
IBA
10/2020
1
Steroids
IBA
09/2020
1
Indicators and Reagents (Reagents)
IBA
01/2019
1
Peptide Nucleic Acids
IBA
01/2018
1
Platinum
IBA
09/2017
1
Pemetrexed (MTA)
FDA Link
07/2017
1
Enzymes
IBA
07/2017
1
Folic Acid (Vitamin M)
FDA Link
Generic
07/2017
1
pirfenidone
IBA
01/2016
1
XELOX
IBA
11/2015
1
amrubicin
IBA
01/2015
1
Silicones
IBA
01/2015
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2015
1
Anaplastic Lymphoma Kinase
IBA
02/2014
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
02/2013
1
Neuregulin-1 (Neuregulin 1)
IBA
02/2013
1
Keratin-7 (Cytokeratin 7)
IBA
12/2012
1
Nucleic Acids
IBA
12/2012
1
Keratin-19 (Keratin 19)
IBA
12/2012
Therapy/Procedure
14
Therapeutics
08/2020 - 08/2006
11
Drug Therapy (Chemotherapy)
09/2017 - 02/2003
7
Metastasectomy
03/2022 - 07/2010
5
Radiotherapy
07/2021 - 08/2006
5
Thoracotomy
06/2015 - 05/2006
4
Segmental Mastectomy (Lumpectomy)
12/2022 - 02/2016
3
Adjuvant Chemotherapy
03/2021 - 09/2017
3
Pneumonectomy (Lung Volume Reduction)
01/2016 - 09/2011
2
Lymph Node Excision (Lymph Node Dissection)
03/2022 - 02/2003
2
Precision Medicine
01/2022 - 08/2020
2
Combined Modality Therapy
03/2021 - 09/2011
2
Immunotherapy
01/2021 - 01/2009
2
Operative Surgical Procedures
01/2020 - 06/2015
2
Chemoradiotherapy
01/2017 - 10/2014
2
Craniotomy
01/2015 - 07/2011
1
Molecular Targeted Therapy
01/2016
1
Chest Tubes (Chest Tube)
01/2015
1
Thoracostomy
01/2015
1
Cytoreduction Surgical Procedures
11/2013